Matches in Nanopublications for { ?s ?p "[Association of the polymorphism for Toll-like receptor 2 with type 1 diabetes susceptibility.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP90551.RAZyFVW3_eYcLYhXHgzYxkrznWPmaz8cM2eWstKWTC6UE130_assertion description "[Association of the polymorphism for Toll-like receptor 2 with type 1 diabetes susceptibility.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP90551.RAZyFVW3_eYcLYhXHgzYxkrznWPmaz8cM2eWstKWTC6UE130_provenance.
- assertion description "[Association of the polymorphism for Toll-like receptor 2 with type 1 diabetes susceptibility.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Association of the polymorphism for Toll-like receptor 2 with type 1 diabetes susceptibility.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP479901.RAhDefRBNAqbzkegx-zSJ1ntZn_ws4jt1z7FZdXitsElI130_assertion description "[Association of the polymorphism for Toll-like receptor 2 with type 1 diabetes susceptibility.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP479901.RAhDefRBNAqbzkegx-zSJ1ntZn_ws4jt1z7FZdXitsElI130_provenance.
- NP62489.RA_C7rcyGy7HjFjRMCzDSf1gaBeL2h4Bv167S70oEGVz4130_assertion description "[Association of the polymorphism for Toll-like receptor 2 with type 1 diabetes susceptibility.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP62489.RA_C7rcyGy7HjFjRMCzDSf1gaBeL2h4Bv167S70oEGVz4130_provenance.
- NP740081.RA_bxmPuKAU7ORfKJaCHFvx11yP7eL7vfMf9FxeeLW1VE130_assertion description "[Association of the polymorphism for Toll-like receptor 2 with type 1 diabetes susceptibility.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP740081.RA_bxmPuKAU7ORfKJaCHFvx11yP7eL7vfMf9FxeeLW1VE130_provenance.